Literature DB >> 17457932

Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation.

Carlijn I Buis1, Robert C Verdonk, Eric J Van der Jagt, Christian S van der Hilst, Maarten J H Slooff, Elizabeth B Haagsma, Robert J Porte.   

Abstract

Nonanastomotic biliary strictures (NAS) are a serious complication after orthotopic liver transplantation (OLT). The exact pathogenesis is unclear. Purpose of this study was to identify risk factors for the development of NAS after OLT. A total of 487 adult liver transplants with a median follow-up of 7.9 years were studied. All imaging studies of the biliary tree were reviewed. Cholangiography was routinely performed between postoperative days 10-14 and later on demand. Localization of NAS at first presentation was categorized into 4 anatomical zones of the biliary tree. Severity of NAS was semiquantified as mild, moderate, or severe. Donor, recipient, and surgical characteristics and variables were analyzed to identify risk factors for NAS. NAS developed in 81 livers (16.6%). Thirty-seven (7.3%) were graded as moderate to severe. In 85% of the cases, anatomical localization of NAS was around or below the bifurcation of the common bile duct. A large variation was observed in the time interval between OLT and first presentation of NAS (median 4.1 months; range 0.3-155 months). NAS presenting early (< or =1 year) after OLT were associated with preservation-related risk factors. Cold and warm ischemia times were significantly longer in patients with early NAS compared with NAS presenting late (>1 year) after OLT (694 minutes vs. 490 minutes, P = 0.01, and 57 minutes vs. 53 minutes, P < 0.05, respectively), and early NAS were more frequently located in the central bile ducts. NAS presenting late (>1 year) after OLT were found more frequently in the periphery of the liver and were more frequently associated with immunological factors, such as primary sclerosing cholangitis, as the indication for OLT (24% vs. 45%, P < 0.05). By separating cases of NAS on the basis of the time of presentation after transplantation, we were able to identify differences in risk factors, indicating different pathogenic mechanisms depending on the time of initial presentation.

Entities:  

Mesh:

Year:  2007        PMID: 17457932     DOI: 10.1002/lt.21166

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  39 in total

Review 1.  Biliary complications following liver transplantation.

Authors:  Walid S Ayoub; Carlos O Esquivel; Paul Martin
Journal:  Dig Dis Sci       Date:  2010-04-22       Impact factor: 3.199

Review 2.  Management of biliary complications after liver transplantation.

Authors:  Riccardo Memeo; Tullio Piardi; Federico Sangiuolo; Daniele Sommacale; Patrick Pessaux
Journal:  World J Hepatol       Date:  2015-12-18

Review 3.  Endoscopic management of benign biliary strictures.

Authors:  Kavel H Visrodia; James H Tabibian; Todd H Baron
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

Review 4.  Endoscopic management of post-liver transplant biliary complications.

Authors:  Mohit Girotra; Kaartik Soota; Jagpal S Klair; Shyam M Dang; Farshad Aduli
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

Review 5.  Endoscopic management of benign biliary strictures.

Authors:  Tarun Rustagi; Priya A Jamidar
Journal:  Curr Gastroenterol Rep       Date:  2015-01

6.  Intraoperative ICG plasma disappearance rate helps to predict absence of early postoperative complications after orthotopic liver transplantation.

Authors:  J J Vos; T W L Scheeren; D J Lukes; M T de Boer; H G D Hendriks; J K G Wietasch
Journal:  J Clin Monit Comput       Date:  2013-05-16       Impact factor: 2.502

Review 7.  Biliary complications in right lobe living donor liver transplantation.

Authors:  Kenneth S H Chok; Chung Mau Lo
Journal:  Hepatol Int       Date:  2016-03-01       Impact factor: 6.047

8.  The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.

Authors:  Tang Yunhua; Ju Weiqiang; Chen Maogen; Yang Sai; Zhang Zhiheng; Wang Dongping; Guo Zhiyong; He Xiaoshun
Journal:  J Clin Monit Comput       Date:  2017-08-22       Impact factor: 2.502

9.  Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers.

Authors:  Qiang Liu; Ahmed Nassar; Kevin Farias; Laura Buccini; William Baldwin; Martin Mangino; Ana Bennett; Colin O'Rourke; Toshiro Okamoto; Teresa Diago Uso; John Fung; Kareem Abu-Elmagd; Charles Miller; Cristiano Quintini
Journal:  Liver Transpl       Date:  2014-07-02       Impact factor: 5.799

10.  Donation after cardio-circulatory death liver transplantation.

Authors:  Hieu Le Dinh; Arnaud de Roover; Abdour Kaba; Séverine Lauwick; Jean Joris; Jean Delwaide; Pierre Honoré; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.